Current challenges in non-invasive insulin delivery systems: A comparative review

被引:326
作者
Khafagy, El-Sayed [1 ]
Morishita, Mariko [1 ]
Onuki, Yoshinori [1 ]
Takayama, Kozo [1 ]
机构
[1] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Ebara 2-4-41, Tokyo 1428501, Japan
关键词
non-invasive delivery system; modern insulin delivery; administration routes; marketed products; formulation technologies; future patents; DIABETES MANAGEMENT-SYSTEM; LOW-FREQUENCY SONOPHORESIS; IN-VITRO EVALUATION; COMPLEXATION POLYMER HYDROGELS; RESPIRABLE PLGA MICROSPHERES; LECITHIN-BASED MICROEMULSION; CHITOSAN BASED FORMULATIONS; INTRA-SUBJECT VARIABILITY; LARGE POROUS PARTICLES; GROWTH-FACTOR-I;
D O I
10.1016/j.addr.2007.08.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The quest to eliminate the needle from insulin delivery and to replace it with non- or less-invasive alternative routes has driven rigorous pharmaceutical research to replace the injectable forms of insulin. Recently, various approaches have been studied involving many strategies using various technologies that have shown success in delivering insulin, which are designed to overcome the inherent barriers for insulin uptake across the gastrointestinal tract, mucosal membranes and skin. This review examines some of the many attempts made to develop alternative, more convenient routes for insulin delivery to avoid existing long-term dependence on multiple subcutaneous injections and to improve the pharmacodynamic properties of insulin. In addition, this article concentrates on the successes in this new millennium in developing potential non-invasive technologies and devices, and on major new milestones in modem insulin delivery for the effective treatment of diabetes. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1521 / 1546
页数:26
相关论文
共 287 条
[31]   Intestinal Peyer's patch M cells and oral vaccine targeting [J].
Brayden, DJ ;
Jepson, MA ;
Baird, AW .
DRUG DISCOVERY TODAY, 2005, 10 (17) :1145-1157
[32]   Micromachined needle arrays for drug delivery or fluid extraction - Design and fabrication aspects of fluid coupled arrays of hollow metallic microneedles [J].
Brazzle, J ;
Papautsky, I ;
Frazier, AB .
IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 1999, 18 (06) :53-58
[33]   Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients [J].
Brunner, GA ;
Balent, B ;
Ellmerer, M ;
Schaupp, L ;
Siebenhofer, A ;
Jendle, JH ;
Okikawa, J ;
Pieber, TR .
DIABETOLOGIA, 2001, 44 (03) :305-308
[34]   THE USE OF ULTRASOUND AS AN ENHANCER FOR TRANSCUTANEOUS DRUG-DELIVERY - PHONOPHORESIS [J].
BYL, NN .
PHYSICAL THERAPY, 1995, 75 (06) :539-553
[35]   Concept, strategies, and feasibility of noninvasive insulin delivery [J].
Cefalu, WT .
DIABETES CARE, 2004, 27 (01) :239-246
[36]  
CEFALU WT, 2002, INSULIN THERAPY, V1, P1
[37]   Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery [J].
Cevc, G .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1996, 13 (3-4) :257-388
[38]   A multichannel neural probe for selective chemical delivery at the cellular level [J].
Chen, JK ;
Wise, KD ;
Hetke, JF ;
Bledsoe, SC .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1997, 44 (08) :760-769
[39]  
Chen XJ, 2002, ACTA PHARMACOL SIN, V23, P467
[40]   Transdermal protein delivery by a coadministered peptide identified via phage display [J].
Chen, YP ;
Shen, YY ;
Guo, X ;
Zhang, CS ;
Yang, WJ ;
Ma, ML ;
Liu, S ;
Zhang, MB ;
Wen, LP .
NATURE BIOTECHNOLOGY, 2006, 24 (04) :455-460